Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	127.28	93.19	41.00
Graham Fair Price	-34.59	5400.53	8256.61
PEG	222.57	-0.05	0.02
Price/Book	4.52	0.22	0.21
Price/Cash Flow	120.77	-19.15	8.67
Prices/Earnings	145.20	7.84	-3.20
Price/Sales	27.41	1.20	0.94
Price/FCF	120.77	-19.15	8.67
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-14.47	0.10	0.11
Operating Margin	-253.48	-0.01	< 0.005
ROA	-57.39	< 0.005	-0.01
ROE	-0.02	< 0.005	-57.37
ROIC	< 0.005	< 0.005	-612.39
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.02	-0.19	-91.56
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.39	-1.89	-35.68
EPS QOQ	-1.88	1.43	-23.99
FCF QOQ	6.04	-1.47	-75.63
Revenue QOQ	0.20	-0.18	-9.93
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	15.07	19.84	31.72
Days Sales Outstanding (DSO)	59.76	69.56	16.40
Inventory Turnover	5.97	4.54	-24.08
Debt/Capitalization	0.02	0.03	6.62
Quick Ratio	1.62	1.44	-11.48
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	13519.86	13544.40	0.18
Cash	2380.54	2006.82	-15.70
Capex	-45.86	-84.44	-84.14
Free Cash Flow	330.26	-156.64	-52.57
Revenue	3042.39	2500.30	-17.82
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.80	1.65	-8.43
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-11.40	-3.62	68.21
Naive Interpretation	Member

06 - Financial Health · Weak

Rating